Oncology Pharma Inc. (OTCMKTS:ONPH – Get Rating) was the target of a large drop in short interest in the month of February. As of February 15th, there was short interest totalling 22,900 shares, a drop of 24.7% from the January 31st total of 30,400 shares. Based on an average daily volume of 98,900 shares, the days-to-cover ratio is presently 0.2 days.

Oncology Pharma Stock Performance

OTCMKTS ONPH remained flat at $0.34 during mid-day trading on Thursday. 25,501 shares of the company traded hands, compared to its average volume of 52,361. The firm's fifty day moving average price is $0.39 and its 200 day moving average price is $0.64. Oncology Pharma has a twelve month low of $0.32 and a twelve month high of $4.40.

Oncology Pharma Company Profile

(Get Rating)

Oncology Pharma, Inc engages in the development, manufacture and commercialization of therapeutics. The company was founded by Marcel van Heesewijk on March 26, 1993 and is headquartered in San Francisco, CA.

See Also

• Get a free copy of the StockNews.com research report on Oncology Pharma (ONPH)
• Hormel Hits 2-Year Low, And The Dip Gets Bought
• Here's Why Ross Could Soon Be Hitting All Time Highs
• The Bottom Is In For Salesforce.com
• It's Time For A Fresh Look At The Kroger Co.
• West Fraser's Earnings Scream Timber, Outlook Says Buy

Receive News & Ratings for Oncology Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Pharma and related companies with MarketBeat.com's FREE daily email newsletter.